Literature DB >> 20379803

Presence of endogenous PACAP-38 ameliorated intestinal cold preservation tissue injury.

Andrea Ferencz1, Gyorgy Weber, Zsuzsanna Helyes, Hitoshi Hashimoto, Akemichi Baba, Dora Reglodi.   

Abstract

Cold preservation tissue injury remains an unsolved problem during small intestinal transplantation. Pituitary adenylate cyclase-activating polypeptide (PACAP) plays a central role in the intestinal physiology. The aim of our study was to compare the cold ischemic injury in wild-type and PACAP-38 deficient mice after small bowel cold storage. Cold ischemia was produced with small bowel preservation in a University of Wisconsin solution at 4°C in wild-type (n = 35) mice for 1 h (GI), for 3 h (GII), and for 6 h (GIII); and in PACAP-38 deficient (n = 35) mice for 1 h (GIV), for 3 h (GV), and for 6 h (GVI). Small bowel biopsies were collected after laparotomy (Control) and at the end of the ischemia periods. To determine oxidative stress parameters, malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD) were measured. Tissue damage was analyzed by qualitative and quantitative methods on hematoxylin/eosin-stained sections. In PACAP-38 deficient animals, tissue lipid peroxidation was elevated. These changes were significant after 6 h (153.04 ± 7.2) compared to sham-operated (110.44 ± 5.5) and compared to wild-type results (120.0 ± 1.1 µmol/g, p < 0.05). Meanwhile, the capacity and activity of the endogenous antioxidant system decreased significantly after 3 and 6 h preservation (GSH: 808.7 ± 5.2; 720.4 ± 8.7 vs. 910.4 ± µmol/g; SOD: 125.1 ± 1.4; 103.3 ± 1.9 vs. 212.11 ± 5.8 IU/g). Qualitative and quantitative histological results showed destruction of the mucous, submucous layers, and crypts in PACAP-38 deficient mice compared to wild-type tissues. These processes depended on the time of the cold preservation periods. Our present study showed that the presence of PACAP-38 in the small bowel tissue has a key role in the protection against intestinal cold preservation injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20379803     DOI: 10.1007/s12031-010-9352-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  The effects of preconditioning on the oxidative stress in small-bowel autotransplantation.

Authors:  Andrea Ferencz; Zalán Szántó; Balázs Borsiczky; Katalin Kiss; Károly Kalmár-Nagy; József Szeberényi; Péter Ors Horváth; Erzsébet Róth
Journal:  Surgery       Date:  2002-11       Impact factor: 3.982

2.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

3.  Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult.

Authors:  David Vaudry; Carol Hamelink; Ruslan Damadzic; Robert L Eskay; Bruno Gonzalez; Lee E Eiden
Journal:  Peptides       Date:  2005-07-11       Impact factor: 3.750

Review 4.  Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract.

Authors:  J M Läuff; I M Modlin; L H Tang
Journal:  Regul Pept       Date:  1999-10-22

5.  Locations and molecular forms of PACAP and sites and characteristics of PACAP receptors in canine ileum.

Authors:  Y K Mao; Y F Wang; C Moogk; J E Fox-Threlkeld; Q Xiao; T J McDonald; E E Daniel
Journal:  Am J Physiol       Date:  1998-01

6.  PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.

Authors:  D Vaudry; T F Pamantung; M Basille; C Rousselle; A Fournier; H Vaudry; J C Beauvillain; B J Gonzalez
Journal:  Eur J Neurosci       Date:  2002-05       Impact factor: 3.386

7.  Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Authors:  Dóra Reglodi; Zsolt Fábián; Andrea Tamás; Andrea Lubics; József Szeberényi; Tamás Alexy; Kálmán Tóth; Zsolt Márton; Balázs Borsiczky; Erzsébet Rõth; Luca Szalontay; István Lengvári
Journal:  Regul Pept       Date:  2004-12-15

8.  Morphological changes of small bowel graft in Wistar rats after preservation injury.

Authors:  P Balaz; I Matia; S Jackanin; M Pomfy; J Fronek; M Ryska
Journal:  Bratisl Lek Listy       Date:  2004       Impact factor: 1.278

9.  PACAP provides colonic protection against dextran sodium sulfate induced colitis.

Authors:  Yasu-Taka Azuma; Kiyomi Hagi; Norihito Shintani; Mitsuru Kuwamura; Hidemitsu Nakajima; Hitoshi Hashimoto; Akemichi Baba; Tadayoshi Takeuchi
Journal:  J Cell Physiol       Date:  2008-07       Impact factor: 6.384

10.  Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP.

Authors:  Nicole Nemetz; Catalina Abad; Greg Lawson; Hiroko Nobuta; Seririthanar Chhith; Lucy Duong; Gary Tse; Jonathan Braun; James A Waschek
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

View more
  7 in total

1.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

2.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

3.  Molecular mechanisms underlying the Nephroprotective effects of PACAP in diabetes.

Authors:  Eszter Banki; Krisztina Kovacs; Daniel Nagy; Tamas Juhasz; Peter Degrell; Katalin Csanaky; Peter Kiss; Gabor Jancso; Gabor Toth; Andrea Tamas; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2014-02-19       Impact factor: 3.444

4.  Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.

Authors:  G Maasz; Z Pirger; D Reglodi; D Petrovics; J Schmidt; P Kiss; A Rivnyak; H Hashimoto; P Avar; E Jambor; A Tamas; B Gaszner; L Mark
Journal:  J Mol Neurosci       Date:  2014-03-19       Impact factor: 3.444

Review 5.  PACAP and its role in primary headaches.

Authors:  Lars Edvinsson; János Tajti; Levente Szalárdy; László Vécsei
Journal:  J Headache Pain       Date:  2018-03-09       Impact factor: 7.277

Review 6.  Targeting the PAC1 Receptor for Neurological and Metabolic Disorders.

Authors:  Chenyi Liao; Mathilde P de Molliens; Severin T Schneebeli; Matthias Brewer; Gaojie Song; David Chatenet; Karen M Braas; Victor May; Jianing Li
Journal:  Curr Top Med Chem       Date:  2019       Impact factor: 3.295

Review 7.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.